These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 25619549)
21. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792 [TBL] [Abstract][Full Text] [Related]
22. Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure. Ikeda Y; Ishii S; Maemura K; Oki T; Yazaki M; Fujita T; Nabeta T; Maekawa E; Koitabashi T; Ako J ESC Heart Fail; 2021 Oct; 8(5):4067-4076. PubMed ID: 34323025 [TBL] [Abstract][Full Text] [Related]
23. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure. Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739 [TBL] [Abstract][Full Text] [Related]
24. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373 [TBL] [Abstract][Full Text] [Related]
25. Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. Pandhi P; Ter Maaten JM; Emmens JE; Struck J; Bergmann A; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; van Veldhuisen DJ; Voors AA Eur J Heart Fail; 2020 Apr; 22(4):683-691. PubMed ID: 31797505 [TBL] [Abstract][Full Text] [Related]
26. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507 [TBL] [Abstract][Full Text] [Related]
27. Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. Butler J; Hernandez AF; Anstrom KJ; Kalogeropoulos A; Redfield MM; Konstam MA; Tang WH; Felker GM; Shah MR; Braunwald E JACC Heart Fail; 2016 Sep; 4(9):726-35. PubMed ID: 27522631 [TBL] [Abstract][Full Text] [Related]
28. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. Yilmaz MB; Gayat E; Salem R; Lassus J; Nikolaou M; Laribi S; Parissis J; Follath F; Peacock WF; Mebazaa A Eur J Heart Fail; 2011 Nov; 13(11):1244-52. PubMed ID: 22024466 [TBL] [Abstract][Full Text] [Related]
29. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes. Miró Ò; Núñez J; Trullàs JC; Lopez-Ayala P; Llauger L; Alquézar-Arbé A; Miñana G; Mollar A; de la Espriella R; Lorenzo M; Jacob J; Espinosa B; Garcés-Horna V; Aguirre A; Fortuny MJ; Martínez-Nadal G; Gil V; Mueller C; Llorens P; ; ; Eur J Intern Med; 2024 Sep; 127():126-133. PubMed ID: 38763846 [TBL] [Abstract][Full Text] [Related]
30. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study. Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210 [TBL] [Abstract][Full Text] [Related]
31. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. Kalogeropoulos AP; Tang WH; Hsu A; Felker GM; Hernandez AF; Troughton RW; Voors AA; Anker SD; Metra M; McMurray JJ; Massie BM; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Butler J J Card Fail; 2014 May; 20(5):319-26. PubMed ID: 24530944 [TBL] [Abstract][Full Text] [Related]
32. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure. Fudim M; Spates T; Sun JL; Kittipibul V; Testani JM; Starling RC; Tang WHW; Hernandez AF; Felker GM; O'Connor CM; Mentz RJ Am Heart J; 2021 Sep; 239():110-119. PubMed ID: 34052212 [TBL] [Abstract][Full Text] [Related]
33. Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure. Zhou HB; Xu TY; Liu SR; Bai YJ; Huang XF; Zhan Q; Zeng QC; Xu DL Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):351-359. PubMed ID: 30795993 [TBL] [Abstract][Full Text] [Related]
34. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600 [TBL] [Abstract][Full Text] [Related]
35. Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial. Ezekowitz J; Alemayehu W; Edelmann F; Ponikowski P; Lam CSP; O'Connor CM; Butler J; Corda S; McMullan CJ; Westerhout CM; Voors AA; Mentz RJ; Armstrong PW; Eur J Heart Fail; 2024 Mar; 26(3):628-637. PubMed ID: 38450878 [TBL] [Abstract][Full Text] [Related]
36. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF. Kittipibul V; Mentz RJ; Clare RM; Wojdyla DM; Anstrom KJ; Eisenstein EL; Ambrosy AP; Goyal P; Skopicki HA; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ; Greene SJ Eur J Heart Fail; 2024 Jul; 26(7):1518-1523. PubMed ID: 38745502 [TBL] [Abstract][Full Text] [Related]
38. Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial. Ferreira JP; Eschalier R; Duarte K; Damman K; Gustafsson F; Schou M; Girerd N; Fay R; Tala S; Pitt B; Zannad F; Rossignol P Circ Heart Fail; 2020 May; 13(5):e006597. PubMed ID: 32354280 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. Kissling KT; Pickworth KK Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816 [TBL] [Abstract][Full Text] [Related]
40. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF. Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]